.png)
.png)
GENITOURINARY / UTI
Elevate your diagnostic precision with our state-of-the-art Urinary Tract Infection (UTI) Panel, meticulously designed to detect a wide range of uropathogens. Our panel accurately differentiates between bacterial and fungal pathogens, guiding healthcare professionals in prescribing the most effective treatments. This ensures patients receive targeted care to alleviate symptoms and prevent recurrence.
Our hallmark UTI Panel enables rapid identification, diagnosis, and therapy initiation. Harness the power of our proprietary Promus Pathway and its validated reporting algorithm, delivering results with 95% sensitivity in CFUs/mL within just 24 hours. Our comprehensive treatment map sets a new standard in patient care, providing rapid, accurate, and actionable insights for superior clinical outcomes. Trust in our expertise to transform your diagnostic capabilities and enhance patient satisfaction.
All results are reported in CFU/mL, allowing providers to utilize PCR sensitivity while treating based on familiar, evidence-based units.
Powered by our proprietary
Elevate your diagnostic precision with our state-of-the-art Urinary Tract Infection (UTI) Panel, meticulously designed to detect a wide range of uropathogens. Our panel accurately differentiates between bacterial and fungal pathogens, guiding healthcare professionals in prescribing the most effective treatments. This ensures patients receive targeted care to alleviate symptoms and prevent recurrence.
Our hallmark UTI Panel enables rapid identification, diagnosis, and therapy initiation. Harness the power of our proprietary Promus Pathway and its validated reporting algorithm, delivering results with 95% sensitivity in CFUs/mL within just 24 hours. Our comprehensive treatment map sets a new standard in patient care, providing rapid, accurate, and actionable insights for superior clinical outcomes. Trust in our expertise to transform your diagnostic capabilities and enhance patient satisfaction.
All results are reported in CFU/mL, allowing providers to utilize PCR sensitivity while treating based on familiar, evidence-based units.
GENITOURINARY / UTI
35
Pathogen Targets
36
Resistance Gene Targets
3
Subpanels Available
11
Antimicrobial Classes
.png)
56
Pathogen Targets
.png)
36
Resistance Gene Targets
.png)
3
Panels Available
.png)
11
Antimicrobial Classes
BACTERIA
Genitourinary System
COLLECTION METHOD(S)
Urine or swab
CLINICAL PRESENTATION
Painful urination, frequent urination, urgency, cloudy or foul-smelling urine, pelvic or back pain, fever, chills, nausea, vomiting, difficulty urinating, discharge
ASSOCIATED DIAGNOSES
Acute UTI, Asymptomatic Bacteriuria, Candiduria, Catheter-Associated UTI (CAUTI), Chronic UTI, Complicated UTI, Cystitis, Fungal UTI, Prostatitis, Pyelonephritis, Urethritis
Comprehensive Genitourinary Panel
BACTERIA
Acinetobacter baumannii complex
Aerococcus urinae
Citrobacter freundii
Enterobacter cloacae complex
Enterococcus faecalis
Enterococcus faecium
Escherichia coli
Klebsiella aerogenes
Klebsiella oxytoca
Klebsiella pneumoniae
Morganella morganii
Mycoplasma genitalium
Mycoplasma hominis
Proteus mirabilis
Proteus vulgaris
Providencia stuartii
Pseudomonas aeruginosa
Staphylococcus aureus
Staphylococcus epidermidis
Staphylococcus haemolyticus
Staphylococcus lugdunensis
Staphylococcus saprophyticus
Streptococcus agalactiae (Group B Strep)
Streptococcus pneumoniae
Streptococcus pyogenes (Group A Streptococcus)
Ureaplasma parvum
Ureaplasma urealyticum
Viridans Group streptococci
VIRUSES
FUNGI
Candida albicans
Candida auris
Candida dubliniensis
Candida glabrata
Candida krusei
Candida parapsilosis
Candida tropicalis
PARASITES
UTI + STI Panel
BACTERIA
Acinetobacter baumannii complex
Chlamydia trachomatis
Citrobacter freundii
Enterobacter cloacae complex
Enterococcus faecalis
Enterococcus faecium
Escherichia coli
Haemophilus ducreyi
Klebsiella aerogenes
Klebsiella oxytoca
Klebsiella pneumoniae
Morganella morganii
Mycoplasma genitalium
Mycoplasma hominis
Neisseria gonorrhoeae
Proteus mirabilis
Proteus vulgaris
Providencia stuartii
Pseudomonas aeruginosa
Staphylococcus aureus
Staphylococcus epidermidis
Staphylococcus haemolyticus
Staphylococcus lugdunensis
Staphylococcus saprophyticus
Streptococcus agalactiae (Group B Strep)
Streptococcus pneumoniae
Streptococcus pyogenes (Group A Streptococcus)
Treponema pallidum
Ureaplasma parvum
Ureaplasma urealyticum
VIRUSES
Herpes Simplex Virus 1 (HSV-1)
Herpes Simplex Virus 2 (HSV-2)
Human Papillomavirus Type 16
Human Papillomavirus Type 18
Human Papillomavirus Type 31
Human Papillomavirus Type 33
Human Papillomavirus Type 35
Human Papillomavirus Type 39
Human Papillomavirus Type 45
Human Papillomavirus Type 51
Human Papillomavirus Type 52
Human Papillomavirus Type 56
Human Papillomavirus Type 58
Human Papillomavirus Type 59
Human Papillomavirus Type 66
Human Papillomavirus Type 68
FUNGI
PARASITES
Trichomonas vaginalis
Cystitis and Pyleonephritis Panel
BACTERIA
Enterobacter cloacae complex
Enterococcus faecalis
Enterococcus faecium
Escherichia coli
Klebsiella aerogenes
Klebsiella oxytoca
Klebsiella pneumoniae
Proteus mirabilis
Proteus vulgaris
Pseudomonas aeruginosa
Staphylococcus aureus
Staphylococcus saprophyticus
Streptococcus agalactiae (Group B Strep)
VIRUSES
FUNGI
PARASITES
Panel #1
BACTERIA
VIRUSES
FUNGI
PARASITES
Panel #1
BACTERIA
VIRUSES
FUNGI
PARASITES
Panel #1
BACTERIA
VIRUSES
FUNGI
PARASITES
_edited.png)
Collection Made Easy
At Promus Diagnostics, we understand that proper specimen collection is the foundation of accurate testing. That’s why our in-house scientists and physicians have worked tirelessly to validate and refine efficient collection methods for our testing panels.
Validated. Integrated. Efficient.
.png)
_edited.png)
A Revolutionary Approach to Testing
Introducing the Promus Pathway by Promus Diagnostics—where advanced technology meets unparalleled efficiency. Our infectious disease test menu provides comprehensive coverage of pathogens and resistance genes, ensuring no clinically relevant infection is overlooked. Designed with healthcare providers in mind, our testing panels are tailored to clinical differentials for seamless ordering while encompassing all essential targets.
We've eliminated complicated metrics with proprietary conversion methodologies developed by our in-house scientists, delivering reports that are both precise and easy to interpret. With expedited turnaround times and results available as soon as the next day, we eliminate delays, reduce antimicrobial guesswork, and empower informed decision-making.
Better testing, better outcomes.
It's that simple.
Key Features
Click the button below to learn more!
100+ specimen targets
Next-day turnaround
CFU/mL reporting
Comprehensive treatment guidance
Polymicrobial infection coverage
100+ specimen targets
Next-day turnaround
CFU/mL reporting
Comprehensive treatment guidance
Polymicrobial infection coverage
Key Features
Click the button below to learn more!
Simple Reporting for Easy Interpretation
Get access to a sample report today!
Enter your email below and we will reply
with a PDF sample report.
Success!
By submitting this form you agree to our Terms of Service.
Additionally, your email will be added to our mailing list.
Simple Reporting for Easy Interpretation
Get access to a sample report today!
Enter your email below and we will reply
with a PDF sample report.
Success!
By submitting this form you agree to our Terms of Service.
Additionally, your email will be added to our mailing list.